Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Internal and Emergency Medicine
|
May 12, 2026
Immediate versus staged revascularization in acute coronary syndrome and multivessel disease: a meta-analysis and meta-regression of RCTs
Felix Bergmann, Anselm Jorda, Theresa Pecho, et al.
Blood Advances
|
June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
Cihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
European Heart Journal. Acute Cardiovascular Care
|
June 6, 2025
Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors
Georg Gelbenegger, Alexandra Julia Lipa, Anselm Jorda, et al.
Allergy
|
March 2, 2026
Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial
Matthias Weiss-Tessbach, Al Medina Dizdarevic, Thorsten Bischof, et al.
Haematologica
|
November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
Katarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 25, 2025
Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial
Katharina Krenn, Felix Kraft, Matthias Urban, et al.
Eclinicalmedicine
|
January 26, 2024
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results
Christian Schoergenhofer, Georg Gelbenegger, Dzenita Hasanacevic, et al.
Blood
|
September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
Cihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trial
Anselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
Journal of the American Society of Nephrology : JASN
|
January 14, 2021
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
Konstantin Doberer, Michael Duerr, Philip F Halloran, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Internal and Emergency Medicine
|
May 12, 2026
Immediate versus staged revascularization in acute coronary syndrome and multivessel disease: a meta-analysis and meta-regression of RCTs
Felix Bergmann, Anselm Jorda, Theresa Pecho, et al.
Blood Advances
|
June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
Cihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
European Heart Journal. Acute Cardiovascular Care
|
June 6, 2025
Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors
Georg Gelbenegger, Alexandra Julia Lipa, Anselm Jorda, et al.
Allergy
|
March 2, 2026
Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial
Matthias Weiss-Tessbach, Al Medina Dizdarevic, Thorsten Bischof, et al.
Haematologica
|
November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
Katarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Anaesthesia, Critical Care & Pain Medicine
|
April 25, 2025
Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial
Katharina Krenn, Felix Kraft, Matthias Urban, et al.
Eclinicalmedicine
|
January 26, 2024
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results
Christian Schoergenhofer, Georg Gelbenegger, Dzenita Hasanacevic, et al.
Blood
|
September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
Cihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trial
Anselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
Journal of the American Society of Nephrology : JASN
|
January 14, 2021
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
Konstantin Doberer, Michael Duerr, Philip F Halloran, et al.
Page
of 6